Kingsgate Consolidated (FRA:KCN) Research & Development: €0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:KCN Kingsgate Consolidated Ltd FRA:KCN
56 GF Score
Price €2.66
GF Value €5.05
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Kingsgate Consolidated Research & Development?

Kingsgate Consolidated FRA:KCN -10.14% 56 Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus rates FRA:KCN with a GF Score™ of 56/100 and a GF Value™ of €5.05 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Kingsgate Consolidated's Research & Development for the six months ended in Dec. 2025 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

Kingsgate Consolidated  (FRA:KCN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Kingsgate Consolidated Research & Development Related Terms

Kingsgate Consolidated Research & Development Historical Data

* Premium members only.

The historical data trend for Kingsgate Consolidated's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kingsgate Consolidated Research & Development Chart

Kingsgate Consolidated Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kingsgate Consolidated Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:KCN
56GF Score
Kingsgate Consolidated Ltd FRA:KCN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kingsgate Consolidated Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Kingsgate Consolidated (FRA:KCN) has a Research & Development of €0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Kingsgate Consolidated and its competitors.
Is Kingsgate Consolidated's Research & Development too high?
Kingsgate Consolidated's current Research & Development is €0.0 Mil. Overall, Kingsgate Consolidated has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kingsgate Consolidated's Research & Development compare to NEM and AU?
Kingsgate Consolidated's Research & Development of €0.0 Mil can be compared against companies in the Metals & Mining industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Metals & Mining company?
A good Research & Development depends on the Metals & Mining industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Kingsgate Consolidated and its competitors. Kingsgate Consolidated's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kingsgate Consolidated stock overvalued right now?
Based on GuruFocus' analysis, Kingsgate Consolidated (FRA:KCN) is currently considered Significantly Undervalued. The stock's GF Value™ is €5.05, compared to a current price of €2.66 — trading 47.4% below its estimated fair value. The current Research & Development is €0.0 Mil. Kingsgate Consolidated's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Kingsgate Consolidated (FRA:KCN), the current Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kingsgate Consolidated (FRA:KCN) Overvalued in 2026?

Based on GuruFocus' analysis, Kingsgate Consolidated stock appears to be undervalued. The current stock price of €2.66 is trading 47.4% below its estimated GF Value™ of €5.05. GuruFocus considers Kingsgate Consolidated to be Significantly Undervalued.

Key valuation signals for FRA:KCN:

  • Research & Development: €0.0 Mil
  • GF Value™: €5.05 vs. price of €2.66 (47.4% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the FRA:KCN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kingsgate Consolidated Business Description

Address 14 Martin Place, Suite 12.07, Level 12, Sydney, NSW, AUS, 2000
Kingsgate Consolidated Ltd is engaged in gold and silver mining, development, and exploration company based in Sydney, Australia. Its operating segment includes Chatree Gold Mine, Thailand, and Nueva Esperanza Gold/Silver Project, Chile. The company derives maximum revenue from the Chatree Gold Mine project.
56GF Score

Get the complete analysis for FRA:KCN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.66
Price
€5.05
GF Value